Case-Finding for Neurocognitive Disorders in Pavia

Launched by IRCCS NATIONAL NEUROLOGICAL INSTITUTE "C. MONDINO" FOUNDATION · May 13, 2025

Keywords

ClinConnect Summary

This clinical trial, called "Case-Finding for Neurocognitive Disorders in Pavia," is focused on improving the early detection and care of dementia and Mild Cognitive Impairment (MCI). Researchers are trying to find out the best ways to identify people who may have these conditions by comparing three different locations: general practitioners' offices, a dedicated Dementia Operations Center, and community events called Open Days. The goal is to see how many individuals can be diagnosed early, which can help them receive the support they need sooner. Additionally, the study will explore the overall impact of two new projects aimed at supporting patients and their caregivers in the Pavia area.

To participate in this trial, individuals must be 50 years or older and have no prior diagnosis of cognitive decline. They also need to understand the study and be able to give their consent to join. Caregivers of patients with suspected or confirmed dementia and healthcare professionals involved in the project can also take part. Participants can expect to receive assessments and support through the new Center for Cognitive Disorders and Dementia, helping to improve their experience and care. This trial is important because it aims to enhance how we detect and manage dementia, ultimately benefiting patients and their families.

Gender

ALL

Eligibility criteria

• For the Primary Outcome the inclusion criteria are:
• • Age 50 or older
• • Assessment conducted using GPcog/ACE-III depending on the setting
• • No prior diagnosis of cognitive decline
• • Ability to understand the study objectives and sign an informed consent
• For the Primary Outcome the exclusion criteria are:
• • Age under 50
• • Presence of a diagnosis of cognitive decline
• • Limited knowledge of the Italian language
• For the secondary outcome the inclusion criteria are:
• Patient:
• • All patients/people who are included in one of the actions provided through the "Ricor-Dare" Project or who are attending a visit scheduled in the clinical-care pathway of the CDCD Fondazione Mondino Pavia or Lomellina;
• • Ability to understand the aims of the study and to sign an informed consent
• Caregiver:
• • Age equal to or greater than 18 years
• • Informal caregiver of a family member with a suspected or confirmed diagnosis of dementia who is included in one of the actions provided through the "Ricor-Dare" project or who are attending a visit scheduled in the clinical-care pathway of the CDCD;
• • Acceptance of informed consent and voluntary participation in the study.
• Healthcare professionals:
• • All healthcare and social healthcare professionals (GPs, pharmacists, nurses, nurses auxiliary) who practice in the cities of Pavia and Vigevano who participate in the project and agree to undergo assessments and training;
• • Acceptance of informed consent and voluntary participation in the study.
• Fo the Secondary Outcome the exclusion criteria are:
• Patient:
• • - Inability to understand the aims of the study and to sign an informed consent
• Caregiver:
• • Age under 18
• • Formal caregivers, i.e. any person who provides assistance to the patient in exchange for payment of a fee;
• • Caregivers with limited knowledge of the Italian language.